Philips gains FDA OK for lightweight AED (automated external defibrillator):
This article was originally published in Clinica
Philips Medical Systems has gained US FDA clearance to sell its FR2 automated external defibrillator (AED) for use by professional responders on conscious patients who are suspected of being in cardiac distress. The portable system weighs less than five pounds and can be used to treat cardiac arrest in patients of all ages, said the firm.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.